BAM
CMPX icon

Belpointe Asset Management’s Compass Therapeutics CMPX Stock Holding History

Belpointe Asset Management’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.5K Buy
+13,025
New +$38.5K ﹤0.01% 1117

Other funds holding CMPX

HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

Belpointe Asset Management's CMPX Position: Q2 2026 in Review

Belpointe Asset Management opened a new position in Compass Therapeutics (CMPX) in Q2 2026: 13,025 shares worth $28.5K. The stake represents ﹤0.01% of the portfolio and ranks #1117 among its holdings.

32 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Belpointe Asset Management held 13,025 shares of Compass Therapeutics worth $28.5K as of Q2 2026.
  • Compass Therapeutics was a new Belpointe Asset Management position in Q2 2026.
  • Compass Therapeutics made up ﹤0.01% of Belpointe Asset Management's portfolio in Q2 2026, its #1117 holding.
  • 32 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Belpointe Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.